Birgit Eiermann

1.1k total citations
19 papers, 746 citations indexed

About

Birgit Eiermann is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Health Information Management. According to data from OpenAlex, Birgit Eiermann has authored 19 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Geriatrics and Gerontology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Health Information Management. Recurrent topics in Birgit Eiermann's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Electronic Health Records Systems (7 papers) and Pharmaceutical studies and practices (7 papers). Birgit Eiermann is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Electronic Health Records Systems (7 papers) and Pharmaceutical studies and practices (7 papers). Birgit Eiermann collaborates with scholars based in Sweden, United Kingdom and United States. Birgit Eiermann's co-authors include Georg Engel, Inger Johansson, Ulrich M. Zanger, Leif Bertilsson, Marine L. Andersson, Ylva Böttiger, Lars L. Gustafsson, Buster Mannheimer, Marie‐Louise Ovesjö and Kari Laine and has published in prestigious journals such as PLoS ONE, The Annual Review of Pharmacology and Toxicology and British Journal of Clinical Pharmacology.

In The Last Decade

Birgit Eiermann

18 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Eiermann Sweden 13 244 189 148 137 133 19 746
Marine L. Andersson Sweden 16 167 0.7× 242 1.3× 66 0.4× 126 0.9× 50 0.4× 32 787
Lisa E. Hines United States 13 471 1.9× 91 0.5× 61 0.4× 150 1.1× 120 0.9× 40 824
Randy C. Hatton United States 18 439 1.8× 122 0.6× 40 0.3× 242 1.8× 96 0.7× 46 1.1k
Ylva Böttiger Sweden 21 200 0.8× 457 2.4× 134 0.9× 329 2.4× 56 0.4× 53 1.4k
Terry Seaton United States 13 200 0.8× 163 0.9× 21 0.1× 88 0.6× 50 0.4× 26 606
Martina Teichert Netherlands 19 235 1.0× 252 1.3× 54 0.4× 124 0.9× 16 0.1× 81 1.1k
Andreas D. Meid Germany 17 390 1.6× 52 0.3× 51 0.3× 114 0.8× 24 0.2× 59 830
Frantz Thiessard France 20 73 0.3× 71 0.4× 60 0.4× 88 0.6× 44 0.3× 60 1.2k
Pim N.J. Langendijk Netherlands 16 122 0.5× 124 0.7× 41 0.3× 88 0.6× 45 0.3× 25 1.1k
William N. Kelly United States 13 274 1.1× 71 0.4× 25 0.2× 140 1.0× 44 0.3× 47 671

Countries citing papers authored by Birgit Eiermann

Since Specialization
Citations

This map shows the geographic impact of Birgit Eiermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Eiermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Eiermann more than expected).

Fields of papers citing papers by Birgit Eiermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Eiermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Eiermann. The network helps show where Birgit Eiermann may publish in the future.

Co-authorship network of co-authors of Birgit Eiermann

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Eiermann. A scholar is included among the top collaborators of Birgit Eiermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Eiermann. Birgit Eiermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hammar, Tora, et al.. (2022). Discrepancies in patients' medication lists from pharmacies in Sweden: an interview study before the implementation of the Swedish National Medication List. International Journal of Clinical Pharmacy. 45(1). 88–96. 8 indexed citations
2.
Eiermann, Birgit, et al.. (2021). ADR databases for on‐site clinical use: Potentials of summary of products characteristics. Basic & Clinical Pharmacology & Toxicology. 128(4). 557–567.
3.
Darwich, Adam S., Thomas M. Polasek, Jeffrey K Aronson, et al.. (2020). Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy. The Annual Review of Pharmacology and Toxicology. 61(1). 225–245. 109 indexed citations
4.
Holm, Johan, Birgit Eiermann, Elin Kimland, & Buster Mannheimer. (2019). Prevalence of potential drug-drug interactions in Swedish pediatric outpatients. PLoS ONE. 14(8). e0220685–e0220685. 8 indexed citations
5.
Andersson, Marine L., et al.. (2017). High Prevalence of Drug–Drug Interactions in Primary Health Care is Caused by Prescriptions from other Healthcare Units. Basic & Clinical Pharmacology & Toxicology. 122(5). 512–516. 21 indexed citations
6.
Hammar, Tora, et al.. (2015). Potential drug-related problems detected by electronic expert support system: physicians’ views on clinical relevance. International Journal of Clinical Pharmacy. 37(5). 941–948. 11 indexed citations
7.
Andersson, Marine L., et al.. (2015). Evaluation of usage patterns and user perception of the drug–drug interaction database SFINX. International Journal of Medical Informatics. 84(5). 327–333. 20 indexed citations
8.
Holm, Johan, Birgit Eiermann, Erik Eliasson, & Buster Mannheimer. (2014). A limited number of prescribed drugs account for the great majority of drug-drug interactions. European Journal of Clinical Pharmacology. 70(11). 1375–1383. 36 indexed citations
9.
Hammar, Tora, et al.. (2014). Potential drug related problems detected by electronic expert support system in patients with multi-dose drug dispensing. International Journal of Clinical Pharmacy. 36(5). 943–952. 17 indexed citations
10.
Eiermann, Birgit, et al.. (2013). Adherence to Drug Label Recommendations for Avoiding Drug Interactions Causing Statin-Induced Myopathy–A Nationwide Register Study. PLoS ONE. 8(8). e69545–e69545. 15 indexed citations
11.
Coleman, Jamie J., Heleen van der Sijs, Walter E. Haefeli, et al.. (2013). On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop. BMC Medical Informatics and Decision Making. 13(1). 111–111. 75 indexed citations
12.
Andersson, Marine L., Ylva Böttiger, Jonatan D. Lindh, Björn Wettermark, & Birgit Eiermann. (2012). Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care. European Journal of Clinical Pharmacology. 69(3). 565–571. 50 indexed citations
13.
Källén, Karin, et al.. (2012). Drugs and Birth Defects: a knowledge database providing risk assessments based on national health registers. European Journal of Clinical Pharmacology. 69(4). 889–899. 12 indexed citations
14.
Eiermann, Birgit, et al.. (2011). Physicians' reported needs of drug information at point of care in Sweden. British Journal of Clinical Pharmacology. 73(1). 115–125. 21 indexed citations
15.
Böttiger, Ylva, Kari Laine, Marine L. Andersson, et al.. (2009). SFINX—a drug-drug interaction database designed for clinical decision support systems. European Journal of Clinical Pharmacology. 65(6). 627–633. 122 indexed citations
16.
Bäckström, Tobias, et al.. (2006). Design and implementation of a point-of-care computerized system for drug therapy in Stockholm metropolitan health region—Bridging the gap between knowledge and practice. International Journal of Medical Informatics. 76(7). 497–506. 31 indexed citations
17.
Strandell, Johanna, et al.. (2006). Can WHO-Database of Suspected ADRs Be Used to Support Existing Information on Pharmacokinetic Drug Interactions?. Drug Safety. 29(10). 911–1010. 1 indexed citations
18.
Eiermann, Birgit, et al.. (1998). 1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans.. PubMed. 26(11). 1096–101. 24 indexed citations
19.
Eiermann, Birgit, Georg Engel, Inger Johansson, Ulrich M. Zanger, & Leif Bertilsson. (1997). The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. British Journal of Clinical Pharmacology. 44(5). 439–446. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marine L. Andersson Breakdown of academic impact, for papers by Lisa E. Hines Breakdown of academic impact, for papers by Randy C. Hatton Breakdown of academic impact, for papers by Ylva Böttiger Breakdown of academic impact, for papers by Terry Seaton Breakdown of academic impact, for papers by Martina Teichert Breakdown of academic impact, for papers by Andreas D. Meid Breakdown of academic impact, for papers by Frantz Thiessard Breakdown of academic impact, for papers by Pim N.J. Langendijk Breakdown of academic impact, for papers by William N. Kelly
Rankless by CCL
2026